UBS on active management: myth busters?
It has again been a very long time since my last post. Sorry again. But I have now decided that it might be fun to get involved in the ongoing discussion over the merits of active management, particularly since so much of it is self-serving nonsense — incidentally on both sides. UBS has now weighed […]
Low beta anomaly – some early evidence
Some of my readers have expressed the view that I am occasionally unnecessarily harsh in my posts. However, it is very unlikely that this post will elicit such a response since it is taking a rather critical look at the entrails of my own dissertation. While that was obviously a very long time ago, what […]